64 results on '"Nortilli R"'
Search Results
2. Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers
3. A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)
4. A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC)
5. ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model
6. Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: Prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer
7. Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival
8. Prognostic impact of proliferation for resected early stage breast cancer according to histology: Cut-off analysis of Ki67 in 859 patients with pure invasive lobular and ductal breast carcinoma (ILC/IDC)
9. Prognostic impact of Ki67 for resected early stage pure Invasive Lobular breast Cancer (ILC): cut-off analysis and clinical validation
10. 197P - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC)
11. Clinical and pathological predictors of Advanced Breast Carcinoma with Luminal subtype (ABC-Lum) identifying prognostic ‘outliers’: multicenter retrospective analysis in the ‘real-world’ scenario
12. Development of a risk model to identity prognostic ‘outliers’ underwent surgery for early-stage invasive lobular breast carcinoma (ILBC) according to clinical and pathological factors
13. La casistica clinica del Coordinamento Interdisciplinare Melanoma Veronese
14. 204P - ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model
15. L’esperienza del Coordinamento Interdisciplinare Melanoma Veronese (C.I.Me.V.)
16. Stereotactic radiosurgery in cerebral metastasis from germ cell tumors
17. Ki-67 in 3130 primary breast cancers: associacions with clinical and pathological variables
18. INvolvement of breast CAncer patients during oncological consultations: A multicentre randomised controlled trial-the INCA study protocol
19. A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results
20. F11 - Prognostic impact of Ki67 for resected early stage pure Invasive Lobular breast Cancer (ILC): cut-off analysis and clinical validation
21. Proliferative activity in 322 breast cancer patients association with prognosis
22. Bone marrow micrometastases in 110 breast cancer patients correlations with clinical-pathological features and prognosis
23. Comparison of two different methods of evaluating proliferative index in breast cancer
24. Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato
25. Bone marrow micrometastases in 120 breast cancer patients
26. Trattamento del melanoma con Interferone Alfa e Dacarbazina
27. Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico
28. Chemioterapia ad alte dosi con trapianto di midollo autologo e fattori di crescita (CSF): razionale, prospettive (problemi di assistenza)
29. Interferon Alfa and Dacarbazina (DTIC) in patients with disseminated malignant melanoma
30. Limite, Trasformazione, Rinascita: rischi 'eccellenti' della crisi
31. Prognosis in breast cancer: significance of estrogen receptors by immunohistochemistry
32. Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario
33. Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi
34. Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.)
35. Micrometastases in bone marrow in breast cancer patients
36. Micrometastases in bone marrow: study in 51 breast cancer patients
37. Significato prognostico e correlazioni clinico patologiche dei recettori per l'estradiolo dosati con metodo biochimico e immunoistochimico
38. Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.)
39. Replicative fraction in breast cancer (b.c.): an immunohistochemical study of 329 cases
40. Attività proliferativa del carcinoma mammario: studio su 329 pazienti
41. Prognostic significance of estrogen receptors (ER), determined by two different methods, in breast cancer (b.c.)
42. The relationship between estrogen receptors (ER) determined by two different methods and prognosis in breast cancer (b.c.)
43. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site
44. L'associazione atenololo-clortalidone nel trattamento ambulatoriale dei pazienti affetti da ipertensione arteriosa moderata
45. [Incidence of retinal and renal complications in arterial hypertension]
46. [Relations between renin activity and vascular complications of arterial hypertension]
47. Significato Prognostico dei recettori per estrogeni (RE) e per progesterone (RP) nel cancro mammario
48. Descrizione di un caso di pre-AIDS
49. Il trattamento medico dei tumori dell'esofago
50. Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.